Arcutis Director Sells $121,000 Amid ZORYVE Revenue Surge
A biotech insider sale of about $121,000 sits beside a strong ZORYVE revenue story. This article breaks down what it ...
We break down no-load fund options for IRAs and what that means for your purchasing costs. Find transparent choices that keep more of your money invested.
27,130 articlesA biotech insider sale of about $121,000 sits beside a strong ZORYVE revenue story. This article breaks down what it ...
Solana’s tokenized equities logged more than $1 billion in weekly volume as of June 20, 2026, illustrating a crypto-s...
A new industry view reframes AI as a productivity boost that reshapes tasks, not a job killer, while Gen Z markets fi...
The Labor Department will unveil the latest jobs data on Thursday, offering a fresh read on June hiring, unemployment...
Over the July Fourth weekend, the seventh film animated franchise led the box office, edging out Toy Story 5 as famil...
Looking for a dependable dividend stock july hold? This article unpacks a durable, long-term pick you can buy in July...
A lifelong surcharge attaches to Part D through a growing base premium, turning late enrollment into a persistent cos...
AMD narrows the AI accelerator gap with NVIDIA as cloud providers diversify their AI infrastructure, signaling a shif...
Palantir stock slipped from its peak, triggering questions about value, risk, and timing for late 2026. This guide br...
RPM International just posted a record Q4 EBIT across its segments. Alongside an insider Form 4 filing, this raises q...
Bitcoin breaks a 12-year trend against gold, signaling a shift in risk sentiment as quantum-era concerns enter mainst...
A week after Walmart’s investor day, the stock surged as analysts highlighted margin discipline and cash returns. Thi...